Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Open Label Study to Evaluate the SeriACL™ Device (Gen IB) for Primary Anterior Cruciate Ligament Repair

NCT00775892 is registered in ClinicalTrials.gov with Serica Technologies, Inc. as lead sponsor.

NCT NCT00775892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00775892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Open Label Study to Evaluate the SeriACL™ Device (Gen IB) for Primary Anterior Cruciate Ligament Repair
Lead sponsor
Serica Technologies, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2008
Completion date
Not reported
Enrollment
30 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament reconstruction